ZBH Insider Trading
ZIMMER BIOMET HOLDINGS, INC. | Orthopedic, Prosthetic & Surgical Appliances & Supplies
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ZIMMER BIOMET HOLDINGS, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2018-08-03 00:12 | 2018-07-31 | Collins Tony W. | Officer - VP, Controller and CAO | OPT+S | $125.77 | 2,778 | $349,386 | 368 | 0.0% |
| 2018-05-24 00:05 | 2018-05-22 | Mazur-Hofsaess Katarzyna | Officer - Pres., Eur., M. East & Afr. | OPT+S | $113.61 | 8,765 | $995,795 | 16,682 | 0.0% |
| 2018-05-01 23:25 | 2018-04-30 | Collins Tony W. | Officer - VP, Controller and CAO | OPT+S | $116.73 | 1,330 | $155,246 | 338 | 0.0% |
| 2018-02-21 00:37 | 2018-02-15 | Hanson Bryan C | Director, Officer - President and CEO | BUY | $119.68 | 25,077 | $3,001,210 | 25,077 | +100.0% |
| 2018-02-14 17:35 | 2018-02-12 | Phipps Chad F | Officer - Sr. VP/Gen Counsel/Secretary | OPT+S | $115.95 | 20,826 | $2,414,754 | 43,017 | 0.0% |
| 2017-12-01 19:00 | 2017-11-29 | Williamson Daniel E. | Officer - Group President | SELL | $116.30 | 6,282 | $730,585 | 2,000 | -75.9% |
| 2017-08-02 23:35 | 2017-07-31 | Collins Tony W. | Officer - VP, Controller and CAO | OPT+S | $121.74 | 16,986 | $2,067,933 | 354 | 0.0% |
| 2017-06-14 00:20 | 2017-06-09 | Yi Sang | Officer - President, Asia Pacific | OPT+S | $124.56 | 17,731 | $2,208,593 | 14 | 0.0% |
| 2017-05-09 14:37 | 2017-05-05 | Phipps Chad F | Officer - Sr. VP/Gen Counsel/Secretary | OPT+S | $116.76 | 6,200 | $723,886 | 36,497 | 0.0% |
| 2017-05-01 23:12 | 2017-04-27 | DVORAK DAVID C | Director, Officer - President and CEO | OPT+S | $116.47 | 87,331 | $10,171,459 | 294,555 | 0.0% |
| 2017-03-21 22:09 | 2017-03-20 | DVORAK DAVID C | Director, Officer - President and CEO | OPT+S | $121.63 | 1,040 | $126,495 | 281,886 | 0.0% |
| 2017-02-07 00:22 | 2017-02-02 | Phipps Chad F | Officer - Sr. VP/Gen Counsel/Secretary | OPT+S | $117.62 | 10,500 | $1,234,981 | 33,762 | 0.0% |
| 2017-02-07 00:21 | 2017-02-02 | Mazur-Hofsaess Katarzyna | Officer - Pres., Eur., M. East & Afr. | OPT+S | $118.00 | 44,195 | $5,215,010 | 11,997 | 0.0% |
| 2017-02-07 00:19 | 2017-02-02 | DVORAK DAVID C | Director, Officer - President and CEO | OPT+S | $117.77 | 43,207 | $5,088,562 | 270,148 | 0.0% |
| 2016-12-05 18:05 | 2016-12-02 | Nolan David A. Jr. | Officer - Group President | OPT+S | $101.11 | 5,050 | $510,619 | 7,989 | 0.0% |
| 2016-09-09 17:37 | 2016-09-08 | Williamson Daniel E. | Officer - Group President | SELL | $129.96 | 2,716 | $352,963 | 2,000 | -57.6% |
| 2016-08-24 21:04 | 2016-08-23 | Kleopfer Stuart G. | Officer - President, Americas | SELL | $129.71 | 3,397 | $440,615 | 3,000 | -53.1% |
| 2016-08-15 18:55 | 2016-08-12 | Collins Tony W. | Officer - VP, Controller and CAO | SELL | $129.16 | 1,287 | $166,223 | 218 | -85.5% |
| 2016-08-11 18:11 | 2016-08-09 | Kleopfer Stuart G. | Officer - President, Americas | SELL | $132.71 | 533 | $70,732 | 0 | -100.0% |
| 2016-08-03 22:19 | 2016-08-01 | Nolan David A. Jr. | Officer - Group President | OPT+S | $130.77 | 25,255 | $3,302,531 | 7,974 | 0.0% |
| 2016-07-12 23:38 | 2016-07-08 | Florin Daniel P | Officer - Sr. VP, CFO | SELL | $124.98 | 15,000 | $1,874,700 | 13,415 | -52.8% |
| 2016-06-16 16:41 | 2016-06-14 | Collins Tony W. | Officer - VP, Controller and CAO | OPT+S | $116.43 | 3,611 | $420,435 | 1,387 | 0.0% |
| 2016-06-10 21:39 | 2016-06-09 | Williamson Daniel E. | Officer - Group President | SELL | $119.49 | 10,000 | $1,194,933 | 4,716 | -68.0% |
| 2016-06-10 21:37 | 2016-06-09 | Kleopfer Stuart G. | Officer - President, Americas | SELL | $119.45 | 11,000 | $1,313,956 | 6,397 | -63.2% |
| 2016-04-19 00:07 | 2016-04-14 | Florin Daniel P | Officer - Sr. VP, CFO | SELL | $114.98 | 10,000 | $1,149,800 | 28,415 | -26.0% |
| 2016-04-15 00:21 | 2016-04-12 | Florin Daniel P | Officer - Sr. VP, CFO | SELL | $110.00 | 12,000 | $1,320,000 | 38,415 | -23.8% |
| 2016-03-23 00:28 | 2016-03-21 | DVORAK DAVID C | Director, Officer - President and CEO | OPT+S | $104.16 | 1,540 | $160,403 | 260,586 | 0.0% |
| 2016-02-13 04:32 | 2016-02-10 | GOLDMAN SACHS GROUP INC | 10% owner | SELL | $96.66 | 3,675,850 | $355,307,661 | 3,856,574 | -48.8% |
| 2016-02-13 04:28 | 2016-02-10 | PRIVATE EQUITY PARTNERS 2004 DIRECT INVESTMENT FUND LP | 10% owner | SELL | $96.66 | 3,675,850 | $355,307,661 | 3,856,574 | -48.8% |
| 2016-02-13 01:27 | 2016-02-10 | BLACKSTONE CAPITAL PARTNERS V L P | 10% owner | SELL | $95.91 | 7,351,708 | $705,102,314 | 0 | -100.0% |
| 2016-02-13 01:11 | 2016-02-10 | Blackstone Group L.P. | 10% owner | SELL | $95.91 | 7,351,708 | $705,102,314 | 0 | -100.0% |
| 2016-02-12 03:23 | 2016-02-09 | TPG Group Holdings (SBS) Advisors, Inc. | Other | SELL | $91.37 | 2 | $196 | 7,351,710 | 0.0% |
| 2016-01-13 00:27 | 2016-01-08 | DVORAK DAVID C | Director, Officer - President and CEO | OPT+S | $102.46 | 44,661 | $4,576,046 | 244,502 | 0.0% |
| 2015-12-04 00:10 | 2015-12-02 | Nolan David A. Jr. | Officer - Group President | OPT+S | $102.62 | 3,435 | $352,499 | 12,139 | 0.0% |
| 2015-11-18 19:51 | 2015-11-16 | Nolan David A. Jr. | Officer - Group President | SELL | $104.85 | 742 | $77,799 | 12,139 | -5.8% |
| 2015-08-10 21:57 | 2015-08-07 | HIGGINS ARTHUR J | Director | BUY | $101.00 | 1,900 | $191,900 | 1,900 | +100.0% |
| 2015-07-01 22:20 | 2015-06-29 | Williamson Daniel E. | Officer - Group President | SELL | $110.98 | 16,000 | $1,775,642 | 14,716 | -52.1% |
| 2015-07-01 22:16 | 2015-06-29 | Kleopfer Stuart G. | Officer - President, Americas | SELL | $110.59 | 18,000 | $1,990,562 | 17,397 | -50.9% |
| 2015-07-01 22:12 | 2015-06-29 | Johnson Adam Rudolph | Officer - Group President | SELL | $110.34 | 30,600 | $3,376,383 | 4,017 | -88.4% |
| 2015-07-01 22:10 | 2015-06-29 | Florin Daniel P | Officer - Sr. VP, CFO | SELL | $107.00 | 5,000 | $535,000 | 50,415 | -9.0% |
| 2005-09-19 17:50 | 2005-09-15 | WHITE AUGUSTUS A | Director | OPT+S | $73.24 | 1,000 | $73,240 | 0 | 0.0% |
| 2005-03-30 23:37 | 2005-03-29 | HERZLINGER REGINA E | Director | OPT+S | $81.72 | 18,102 | $1,479,306 | 40 | 0.0% |
| 2005-02-18 23:59 | 2005-02-16 | LENO SAM R | Officer - EVP Finance and Ops and CFO | OPT+S | $84.38 | 60,000 | $5,062,848 | 56,813 | 0.0% |
| 2005-02-18 19:59 | 2005-02-17 | WHITE AUGUSTUS A | Director | OPT+S | $85.00 | 1,667 | $141,695 | 0 | 0.0% |
| 2005-02-17 21:56 | 2005-02-15 | CONLEY SHERYL L | Officer - President, Global Prods. Group | OPT+S | $82.65 | 24,434 | $2,019,470 | 2,559 | 0.0% |
| 2005-02-16 23:43 | 2005-02-14 | LENO SAM R | Officer - EVP Finance and Ops and CFO | OPT+S | $83.39 | 40,000 | $3,335,632 | 56,813 | 0.0% |
| 2005-02-16 23:42 | 2005-02-14 | ELLIOTT JOHN RAYMOND | Director, Officer - Chairman, Pres. & CEO | OPT+S | $83.27 | 151,749 | $12,636,519 | 62,751 | 0.0% |
| 2005-02-15 18:25 | 2005-02-11 | ELLIOTT JOHN RAYMOND | Director, Officer - Chairman, Pres. & CEO | OPT+S | $84.96 | 50,583 | $4,297,415 | 62,751 | 0.0% |
| 2005-02-11 22:33 | 2005-02-09 | WHITE AUGUSTUS A | Director | OPT+S | $85.05 | 3,333 | $283,468 | 0 | 0.0% |
| 2005-02-11 00:11 | 2005-02-08 | ELLIOTT JOHN RAYMOND | Director, Officer - Chairman, Pres. & CEO | OPT+S | $84.59 | 151,749 | $12,836,296 | 62,751 | 0.0% |
How to Interpret $ZBH Trades
Not every insider transaction in ZIMMER BIOMET HOLDINGS, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ZBH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ZBH
Insider activity data for ZIMMER BIOMET HOLDINGS, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ZBH, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.